Lifeways Group

Belkins
The Lifeways Group is a UK market leader in support services for adults with diverse and often complex needs. Our vision is to deliver high quality, local services to transform people’s lives. We are driven by personal progress and ensure our services are individually tailored to the people we support.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

DIFRENT AND VISIONABLE ANNOUNCE PARTNERSHIP TO EMPOWER HEALTHCARE TRANSFORMATION THROUGH VIDEO COLLABORATION

January 15, 2020

news image

Healthcare video collaboration platform Visionable has announced a partnership with professional services company Difrent to help healthcare organisations work more efficiently. The strategic alliance will support clinical teams in the NHS to facilitate virtual clinician-to-patient consultation, shared clinical decision making, and access to specialist resources through Visionable’s clinical-grade platform. From this month, Visionable’s existing NHS clients will be offered the opport...

Read More

SYTRUE OFFERS FREE AI-BASED SOLUTIONS TO FIGHT THE COVID-19 PANDEMIC

April 02, 2020

news image

The solution will support efforts to identify COVID-19 disease trends and can assist in the development of potential therapies. In an effort to help researchers and governments battling the COVID-19 pandemic make earlier detection and interventions possible, SyTrue, Inc., a provider of Natural Language Processing (NLP) solutions, today announced the Company will provide its SyHealthTM for Population Health solution free of charge to qualified global public health organizations. As increasing num...

Read More

IBM WATSON HEALTH LAUNCHES DATA-DRIVEN TOOL TO OPTIMIZE CLINICAL TRIALS

February 18, 2020

news image

IBM Watson Health today unveiled its newest cloud-based technology IBM Study Advance at the 11th Annual Summit for Clinical Ops Executives (SCOPE). The data-driven, study design tool, is designed to optimize clinical trial protocol design by merging automated access to real-world patient population data, standardizing protocol template guidance and providing a collaborative workspace designed to facilitate efficiency. On average, a single protocol amendment to a Phase III clinical trial ca...

Read More

January 15, 2020

news image

DIFRENT AND VISIONABLE ANNOUNCE PARTNERSHIP TO EMPOWER HEALTHCARE TRANSFORMATION THROUGH VIDEO COLLABORATION

Healthcare video collaboration platform Visionable has announced a partnership with professional services company Difrent to help healthcare organisations work more efficiently. The strategic alliance will support clinical teams in the NHS to facilitate virtual clinician-to-patient consultation, shared clinical decision making, and access to specialist resources through Visionable’s clinical-grade platform. From this month, Visionable’s existing NHS clients will be offered the opport...

Read More

April 02, 2020

news image

SYTRUE OFFERS FREE AI-BASED SOLUTIONS TO FIGHT THE COVID-19 PANDEMIC

The solution will support efforts to identify COVID-19 disease trends and can assist in the development of potential therapies. In an effort to help researchers and governments battling the COVID-19 pandemic make earlier detection and interventions possible, SyTrue, Inc., a provider of Natural Language Processing (NLP) solutions, today announced the Company will provide its SyHealthTM for Population Health solution free of charge to qualified global public health organizations. As increasing num...

Read More

February 18, 2020

news image

IBM WATSON HEALTH LAUNCHES DATA-DRIVEN TOOL TO OPTIMIZE CLINICAL TRIALS

IBM Watson Health today unveiled its newest cloud-based technology IBM Study Advance at the 11th Annual Summit for Clinical Ops Executives (SCOPE). The data-driven, study design tool, is designed to optimize clinical trial protocol design by merging automated access to real-world patient population data, standardizing protocol template guidance and providing a collaborative workspace designed to facilitate efficiency. On average, a single protocol amendment to a Phase III clinical trial ca...

Read More